NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.
about
Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome.Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)Update on Pyrin Functions and Mechanisms of Familial Mediterranean FeverAutoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's diseasePotential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.Blau syndrome, the prototypic auto-inflammatory granulomatous diseaseAutoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.An update on autoinflammatory diseasesMonogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis.Blocking interleukin-1 in rheumatic diseasesReceptor interacting protein-2 plays a critical role in human lung epithelial cells survival in response to Fas-induced cell-death.Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesNLRs in immune privileged sitesAn expanding role for interleukin-1 blockade from gout to cancer.Aberrant interleukin-1 signalling does not increase susceptibility of mice to NOD2-dependent uveitis.Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.Autoinflammation: translating mechanism to therapy.Interplay between innate and adaptive immunity in the development of non-infectious uveitisTherapy of autoinflammatory syndromes.NOD2/CARD15 gene mutation identified in a Chinese family with Blau syndrome.Somatic NOD2 mosaicism in Blau syndromeMolecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.Uveitis, the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT), and intravitreal biologics for ocular inflammation.Activation of NOD2 in vivo induces IL-1beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signalingNovel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behçet's diseaseBiological treatments: new weapons in the management of monogenic autoinflammatory disordersThe NOD2 defect in Blau syndrome does not result in excess interleukin-1 activityMonogenic autoinflammatory diseases: concept and clinical manifestations.The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies.The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.NOD-like receptors and inflammation.NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain.Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.A familial case of Blau syndrome caused by a novel NOD2 genetic mutation.A review and update on orphan drugs for the treatment of noninfectious uveitisTreating inflammation by blocking interleukin-1 in humans.Clinical immunology review series: An approach to the patient with a periodic fever syndrome.Ocular manifestations of the autoinflammatory syndromes.Blau syndrome-associated uveitis and the NOD2 gene.Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature.
P2860
Q22000829-8C467AD7-D4F6-438D-A2AB-7CAA5ED20974Q24631660-8DDAF3D8-F985-4354-907E-54863FAC419AQ26749573-CB19261C-9B76-49D8-B23C-E61AE6F19F3DQ26778253-357CFED2-60F9-465C-B82D-F86F7E9029DFQ33710807-0E1FA339-74C8-4DAD-9334-A21C0EBD4388Q34060987-5A3AACA4-2654-46F1-9353-4C55FCB3A7EAQ34369278-E206E7E8-D34C-4CD5-9FE1-8E9F37810FECQ34380526-800BD956-439F-4546-9F45-B3A59925047DQ34489840-D437B982-1341-4D71-9406-1EDE0F9659DFQ34822708-F5A669F1-67F7-4FA0-B2D0-C8F0C1E96C6EQ35128297-FE99CB34-CB79-458B-BD67-7B8B0D3C1C37Q35133812-FA231BA1-4279-432D-9949-761957985A86Q35169896-1B759EE5-3EEC-4A21-B908-B7927A30DF43Q35219001-FB6A0DBC-A2B8-43A5-8CCB-26BB6ADB51EFQ35220614-A185E303-5E08-4A69-8CCC-A5195B4C87BFQ35443835-2660F8F5-ED4A-49CC-ACBB-0B0A945573B5Q35558406-7358C958-2ED7-4A25-AF52-4DE400A3122DQ35784059-B9576026-FD54-4F8B-8698-9ADD5B6079A9Q35868028-3A130933-7FC8-49F3-BE87-E3B521CD2617Q35883296-2D8380EF-D9A0-4865-A278-DD6DA4C94441Q35931519-5825E38A-22E1-4405-8630-02D4DF7C09C1Q36041225-79F6B147-2FBD-4097-AD04-86B42F0BC062Q36174993-19407968-28DA-431F-90BB-16A74F1CCEDDQ36803813-77322972-1B4E-467D-BD74-3058FD90B7BBQ36882843-9A026C07-5E0C-453B-8947-45FDC4406E8FQ37077564-9B651C4F-F5E4-4935-A9D0-A97E598CE26BQ37124443-9A446A84-3BF5-4477-80D0-0BB3789FB342Q37162157-7C5EB879-8272-441E-8B5D-0E4F8E8B47E6Q37208960-CDA1D37F-6984-4704-94FE-9B4E4A7F28EDQ37270409-9A7DA879-73F4-417C-B672-0076E2E43652Q37353179-FFE564F8-D4B0-4168-90A6-5A4EF98DCAB5Q37401815-2C0EC2E3-4C03-40D6-AA28-7A99AFE6D276Q37466515-9573EEEC-C500-40C1-B827-131541F63BD0Q37525669-E239C99A-F563-4FDA-9F51-DB1E6C5FF86FQ37632096-9FFE7AD6-E7C0-4A8C-AF35-15A391B36800Q37636664-B914D522-BD05-4889-8849-7FF914B0CE42Q37898725-30B5FA86-B827-45A7-86F8-81152A8F5C06Q38038253-D57C0C88-BD71-4F4F-9FFE-D171905279AEQ38134785-415608F6-C67E-4658-80ED-FEAC6702E32FQ38180294-3892F975-E851-4FCE-A659-78662E3108A0
P2860
NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
NOD2 gene-associated pediatric ...... blockade in a Spanish cohort.
@en
type
label
NOD2 gene-associated pediatric ...... blockade in a Spanish cohort.
@en
prefLabel
NOD2 gene-associated pediatric ...... blockade in a Spanish cohort.
@en
P2093
P356
P1476
NOD2 gene-associated pediatric ...... blockade in a Spanish cohort.
@en
P2093
Antonio Naranjo
Consuelo Modesto
Cristina Arnal
Eduardo Ramos
Jordi Yagüe
Josefa Rius
Julia García-Consuegra
María Antonia Carballo
Pilar de Paz
Purificación Moreno
P304
P356
10.1002/ART.22966
P577
2007-11-01T00:00:00Z